Matches in Wikidata for { <http://www.wikidata.org/entity/Q91293970> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q91293970 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91293970 description "bài báo khoa học" @default.
- Q91293970 description "scientific article published on 15 November 2019" @default.
- Q91293970 description "wetenschappelijk artikel" @default.
- Q91293970 description "наукова стаття, опублікована 15 листопада 2019" @default.
- Q91293970 name "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical tr" @default.
- Q91293970 name "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical tr" @default.
- Q91293970 type Item @default.
- Q91293970 label "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical tr" @default.
- Q91293970 label "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical tr" @default.
- Q91293970 prefLabel "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical tr" @default.
- Q91293970 prefLabel "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical tr" @default.
- Q91293970 P1433 Q91293970-795F82D0-8C90-424F-A472-7B04A23EAF22 @default.
- Q91293970 P1476 Q91293970-83F34E2C-83D2-42A3-86AE-188FCAF32B1C @default.
- Q91293970 P2093 Q91293970-13B77F9F-3CFB-4CF1-99F0-FB332AEF737B @default.
- Q91293970 P2093 Q91293970-224F2A11-1CB8-45C6-A4FD-47AD0473E9DC @default.
- Q91293970 P2093 Q91293970-7C918479-BCAF-4FC3-ABD3-FBEBD93CF7C6 @default.
- Q91293970 P2093 Q91293970-7CB7EF65-3974-49F5-986E-0AAC4C32AFED @default.
- Q91293970 P2093 Q91293970-8AD367A1-1DA8-4D82-809D-55E98BA2F684 @default.
- Q91293970 P2093 Q91293970-91E4F971-BF75-4AFE-8C6D-072470C6DD1C @default.
- Q91293970 P2093 Q91293970-ADA58EC4-6718-4939-B285-220D9B0020A6 @default.
- Q91293970 P2093 Q91293970-CE805CA9-B6CB-4441-91B1-4CCF6F6889A4 @default.
- Q91293970 P2093 Q91293970-D8B36464-5B0D-4849-A6C6-09B1FBCE498A @default.
- Q91293970 P2093 Q91293970-FCD61C74-00C9-4C0A-A443-353C22041BA0 @default.
- Q91293970 P304 Q91293970-4D385B29-4467-420A-9050-8F8FA17115EC @default.
- Q91293970 P31 Q91293970-690FCF25-17D1-4E50-B1CA-6357A920FE74 @default.
- Q91293970 P356 Q91293970-6B544D21-2360-4832-976B-A6978A6B0929 @default.
- Q91293970 P433 Q91293970-D72E59B7-43F4-4BC8-A5AF-D570E07F19CC @default.
- Q91293970 P478 Q91293970-223281A2-D035-4817-9AB1-022353CA1A17 @default.
- Q91293970 P50 Q91293970-4CE7DDA0-3A1F-46F3-AD5E-FC5B36888EE8 @default.
- Q91293970 P577 Q91293970-609C8DB5-767C-440E-98F4-746F5A7A52FA @default.
- Q91293970 P698 Q91293970-7576DA69-64FE-4EF5-8205-E0894AD7D15A @default.
- Q91293970 P921 Q91293970-A67063FF-EAC5-4B6D-A688-EBC21FF83077 @default.
- Q91293970 P932 Q91293970-DBAF39D1-E859-4668-AC5F-C7294D57B7EB @default.
- Q91293970 P356 S12885-019-6289-6 @default.
- Q91293970 P698 31729964 @default.
- Q91293970 P1433 Q326300 @default.
- Q91293970 P1476 "ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial" @default.
- Q91293970 P2093 "ACRNaCT study group" @default.
- Q91293970 P2093 "Dakui Luo" @default.
- Q91293970 P2093 "Ji Zhu" @default.
- Q91293970 P2093 "Lei Liang" @default.
- Q91293970 P2093 "Lifeng Yang" @default.
- Q91293970 P2093 "Qi Liu" @default.
- Q91293970 P2093 "Qingguo Li" @default.
- Q91293970 P2093 "Sanjun Cai" @default.
- Q91293970 P2093 "Yanlei Ma" @default.
- Q91293970 P2093 "Zhen Zhang" @default.
- Q91293970 P304 "1117" @default.
- Q91293970 P31 Q13442814 @default.
- Q91293970 P356 "10.1186/S12885-019-6289-6" @default.
- Q91293970 P433 "1" @default.
- Q91293970 P478 "19" @default.
- Q91293970 P50 Q61141558 @default.
- Q91293970 P577 "2019-11-15T00:00:00Z" @default.
- Q91293970 P698 "31729964" @default.
- Q91293970 P921 Q6934595 @default.
- Q91293970 P932 "6858777" @default.